Actoxumab (Anti-Cdiff Toxin A)

Synonyms: Anti-C. difficile Toxin A Recombinant Antibody

Actoxumab ( (Anti-Cdiff Toxin A) is a antitoxin antibody against C. difficile toxin A by neutralizing TcdA. Actoxumab prevents both the damage to the gut wall and the inflammatory response, which are associated with C. difficile. Actoxumab has synergy effect with Bezlotoxumab targeting TcdB. MW: 145.5 KD.

Actoxumab (Anti-Cdiff Toxin A)

Purity & Quality Control

Biological Activity

Description Actoxumab ( (Anti-Cdiff Toxin A) is a antitoxin antibody against C. difficile toxin A by neutralizing TcdA. Actoxumab prevents both the damage to the gut wall and the inflammatory response, which are associated with C. difficile. Actoxumab has synergy effect with Bezlotoxumab targeting TcdB. MW: 145.5 KD.

Product Details

CAS No. 1245634-25-6
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Actoxumab (Anti-Cdiff Toxin A) | Actoxumab (Anti-Cdiff Toxin A) supplier | purchase Actoxumab (Anti-Cdiff Toxin A) | Actoxumab (Anti-Cdiff Toxin A) cost | Actoxumab (Anti-Cdiff Toxin A) manufacturer | order Actoxumab (Anti-Cdiff Toxin A) | Actoxumab (Anti-Cdiff Toxin A) distributor